Adma Biologics (ADMA)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
| 03-2022 | 12-2021 | 09-2021 | 06-2021 | 03-2021 | |
| Assets | |||||
| Current Assets | |||||
| Cash & Cash Equivalents | 69,505 | 51,089 | 34,411 | 42,409 | 61,966 |
| Receivables | 25,630 | 28,577 | 20,393 | 23,545 | 15,362 |
| Inventories | 139,146 | 124,724 | 114,123 | 99,700 | 94,146 |
| TOTAL | $239,800 | $208,729 | $174,785 | $171,355 | $177,277 |
| Non-Current Assets | |||||
| PPE Net | 53,221 | 50,935 | 48,394 | 46,487 | 44,176 |
| Intangibles | 5,079 | 5,258 | 5,437 | 5,616 | 5,795 |
| Other Non-Current Assets | 9,932 | 11,330 | 10,025 | 9,356 | 8,420 |
| TOTAL | $68,232 | $67,523 | $63,855 | $61,459 | $58,391 |
| Total Assets | $308,033 | $276,253 | $238,640 | $232,814 | $235,667 |
| Liabilities | |||||
| Current Liabilities | |||||
| Accounts payable and accrued liabilities | 14,115 | 12,429 | 17,283 | 6,168 | 12,153 |
| Accrued Expenses | 16,655 | 17,215 | 14,410 | 11,490 | 8,592 |
| TOTAL | $31,567 | $30,378 | $32,337 | $18,186 | $21,206 |
| Non-Current Liabilities | |||||
| Long Term Debt | 138,423 | 94,866 | 94,363 | 93,877 | 93,413 |
| Deferred Revenues | 143 | 143 | 143 | 143 | 143 |
| Other Non-Current Liabilities | 1,886 | 397 | 233 | 36 | 42 |
| TOTAL | $149,533 | $104,702 | $103,523 | $103,034 | $101,957 |
| Total Liabilities | $181,099 | $135,080 | $135,860 | $121,220 | $123,163 |
| Shareholders' Equity | |||||
| Shares Outstanding, K | 196,352 | 195,920 | 195,814 | 132,770 | 128,190 |
| Common Shares | 20 | 20 | 14 | 13 | 12 |
| Retained earnings | -437,121 | -412,113 | -395,463 | -377,750 | -358,845 |
| TOTAL | $126,933 | $141,173 | $102,780 | $111,594 | $112,504 |
| Total Liabilities And Equity | $308,033 | $276,253 | $238,640 | $232,814 | $235,667 |